<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337860</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Blood Supply Pathophysiological Microcirculatory Mechanism for Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1076</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14091076</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The term "Long COVID" is commonly used to describe persisting symptoms after acute COVID-19. Until now, proposed mechanisms for the explanation of Long COVID have not related quantitative measurements to basic laws. In this work, a common framework for the Long COVID pathophysiological mechanism is presented, based on the blood supply deprivation and the flow diffusion equation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Case-control studies with statistically significant differences between cases (post-COVID patients) and controls, from multiple tissues and geographical areas, were gathered and tabulated. Microvascular loss (ML) was quantified by vessel density reduction (VDR), foveal avascular zone enlargement (FAZE), capillary density reduction (CDR), and percentage of perfused vessel reduction (PPVR). Both ML and hemodynamic decrease (HD) were incorporated in the tissue blood supply reduction (SR) estimation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ML data were found from 763 post-COVID patients with an average VDR, FAZE, CDR, and PPVR of 16%, 31%, 14%, and 21%, respectively. The average HD from 72 post-COVID patients was 37%. The estimated SR for multiple tissues with data from 634 post-COVID patients reached a sizeable 47%. This large SR creates conditions of lower mass diffusion rates, hypoxia, and undernutrition, which at a multi-tissue level, for a long time, can explain the wide variety of the Long COVID symptoms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Disruption of peripheral tissue blood supply by the contribution of both ML and HD is proposed here to be the principal cause of the mechanism leading to Long COVID symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koutsiaris</LastName><ForeName>Aristotle G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0003-3384-3998</Identifier><AffiliationInfo><Affiliation>Medical Informatics and Biomedical Imaging (MIBI) Laboratory, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis Campus, 41500 Larissa, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood supply</Keyword><Keyword MajorTopicYN="N">case&#x2013;control studies</Keyword><Keyword MajorTopicYN="N">diffusion</Keyword><Keyword MajorTopicYN="N">hemodynamics</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mechanism</Keyword><Keyword MajorTopicYN="N">microcirculation</Keyword><Keyword MajorTopicYN="N">microthrombosis</Keyword><Keyword MajorTopicYN="N">microvascular loss</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword></KeywordList><CoiStatement>The author declares no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337860</ArticleId><ArticleId IdType="pmc">PMC11433432</ArticleId><ArticleId IdType="doi">10.3390/life14091076</ArticleId><ArticleId IdType="pii">life14091076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO (World Health Organization) COVID-19 Weekly Epidemiological Update. 144th ed. WHO; Geneva, Switzerland: 2023.</Citation></Reference><Reference><Citation>WHO (World Health Organization) COVID-19 Weekly Epidemiological Update. 168th ed. WHO; Geneva, Switzerland: 2024.</Citation></Reference><Reference><Citation>Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sideratou C.M., Papaneophytou C. Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems. Infect. Dis. Rep. 2023;15:806&#x2013;830. doi: 10.3390/idr15060072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr15060072</ArticleId><ArticleId IdType="pmc">PMC10742861</ArticleId><ArticleId IdType="pubmed">38131885</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsiaris A.G., Riri K., Boutlas S., Panagiotou T.N., Kotoula M., Daniil Z., Tsironi E.E. COVID-19 hemodynamic and thrombotic effect on the eye microcirculation after hospitalization: A quantitative case-control study. Clin. Hemorheol. Microcirc. 2022;82:379&#x2013;390. doi: 10.3233/CH-221554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-221554</ArticleId><ArticleId IdType="pubmed">35912735</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsiaris A.G., Riri K., Boutlas S., Daniil Z., Tsironi E.E. A normative blood velocity model in the exchange microvessels for discriminating health from disease: Healthy controls versus COVID-19 cases. Clin. Hemorheol. Microcirc. 2023;84:215&#x2013;226. doi: 10.3233/CH-231780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-231780</ArticleId><ArticleId IdType="pubmed">37182862</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020. Morb. Mortal. Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557. Erratum in: JAMA Cardiol. 2020, 5, 1308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezel-Potts E., Douiri A., Sun X., Chowienczyk P.J., Shah A.M., Gulliford M.C. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PLoS Med. 2022;19:e1004052. doi: 10.1371/journal.pmed.1004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004052</ArticleId><ArticleId IdType="pmc">PMC9295991</ArticleId><ArticleId IdType="pubmed">35853019</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I., Fonseca-Rodr&#xed;guez O., Farrington P., Jerndal H., Lundevaller E.H., Sund M., Lindmark K., Fors Connolly A.M. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: Nationwide self-controlled cases series and matched cohort study. BMJ. 2022;377:e069590. doi: 10.1136/bmj-2021-069590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Percze A.R., Nagy A., Polivka L., Barczi E., Czaller I., Kovats Z., Varga J.T., Ballai J.H., Muller V., Horvath G. Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms. Inflammopharmacology. 2023;31:2819&#x2013;2825. doi: 10.1007/s10787-023-01190-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01190-4</ArticleId><ArticleId IdType="pmc">PMC10075170</ArticleId><ArticleId IdType="pubmed">37020055</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648. Erratum in: BMJ 2021, 374, n1944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum P., Do L., Deterding L., Lier J., Kunis I., Saur D., Classen J., Wirtz H., Laufs U. Cardiac function in relation to functional status and fatigue in patients with post-COVID syndrome. Sci. Rep. 2022;12:19575. doi: 10.1038/s41598-022-24038-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24038-3</ArticleId><ArticleId IdType="pmc">PMC9664421</ArticleId><ArticleId IdType="pubmed">36380000</ArticleId></ArticleIdList></Reference><Reference><Citation>Merikanto I., Dauvilliers Y., Chung F., Wing Y.K., De Gennaro L., Holzinger B., Bjorvatn B., Morin C.M., Penzel T., Benedict C., et al. Sleep symptoms are essential features of long-COVID&#x2013;Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II) J. Sleep Res. 2023;32:e13754. doi: 10.1111/jsr.13754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.13754</ArticleId><ArticleId IdType="pmc">PMC9874584</ArticleId><ArticleId IdType="pubmed">36208038</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalamara E., Pataka A., Boutou A., Panagiotidou E., Georgopoulou A., Ballas E., Chloros D., Metallidis S., Kioumis I., Pitsiou G. Persistent Sleep Quality Deterioration among Post-COVID-19 Patients: Results from a 6-Month Follow-Up Study. J. Pers. Med. 2022;12:1909. doi: 10.3390/jpm12111909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12111909</ArticleId><ArticleId IdType="pmc">PMC9692708</ArticleId><ArticleId IdType="pubmed">36422085</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Tallawy S.N., Perglozzi J.V., Ahmed R.S., Kaki A.M., Nagiub M.S., LeQuang J.K., Hadarah M.M. Pain Management in the Post-COVID Era-An Update: A Narrative Review. Pain Ther. 2023;12:423&#x2013;448. doi: 10.1007/s40122-023-00486-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-023-00486-1</ArticleId><ArticleId IdType="pmc">PMC9971680</ArticleId><ArticleId IdType="pubmed">36853484</ArticleId></ArticleIdList></Reference><Reference><Citation>Peron J.P.S. Direct and indirect impact of SARS-CoV-2 on the brain. Hum. Genet. 2023;142:1317&#x2013;1326. doi: 10.1007/s00439-023-02549-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-023-02549-x</ArticleId><ArticleId IdType="pmc">PMC10066989</ArticleId><ArticleId IdType="pubmed">37004544</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsiaris A.G. The velocity-diffusion equation in the exchange microvessels. Clin. Hemorheol. Microcirc. 2023;84:83&#x2013;88. doi: 10.3233/CH-231713.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-231713</ArticleId><ArticleId IdType="pubmed">36911932</ArticleId></ArticleIdList></Reference><Reference><Citation>Renkin E.M. B.W. Zweifach award lecture: Regulation of the microcirculation. Microvasc. Res. 1985;30:251&#x2013;263. doi: 10.1016/0026-2862(85)90057-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-2862(85)90057-3</ArticleId><ArticleId IdType="pubmed">4088091</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung F., K&#xf6;rber N., Kiesewetter H., Pr&#xfc;nte C., Wolf S., Reim M. Measuring the microcirculation in the human conjunctiva bulbi under normal and hyperperfusion conditions. Graefes Arch. Clin. Exp. Ophthalmol. 1983;220:294&#x2013;297. doi: 10.1007/BF00231359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00231359</ArticleId><ArticleId IdType="pubmed">6629023</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsiaris A.G. Meta-analysis of conjunctival microvascular hemorheology metrics. Microvasc. Res. 2022;142:104369. doi: 10.1016/j.mvr.2022.104369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2022.104369</ArticleId><ArticleId IdType="pubmed">35413294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zharkikh E.V., Loktionova Y.I., Fedorovich A.A., Gorshkov A.Y., Dunaev A.V. Assessment of Blood Microcirculation Changes after COVID-19 Using Wearable Laser Doppler Flowmetry. Diagnostics. 2023;13:920. doi: 10.3390/diagnostics13050920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13050920</ArticleId><ArticleId IdType="pmc">PMC10000665</ArticleId><ArticleId IdType="pubmed">36900064</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., Zhou Y., Zheng N., Cai A., Ning Q., et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J. Clin. Investig. 2021;131:e147329. doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsiaris A.G., Batis V., Liakopoulou G., Tachmitzi S.V., Detorakis E.T., Tsironi E.E. Optical Coherence Tomography Angiography (OCTA) of the eye: A review on basic principles, advantages, disadvantages and device specifications. Clin. Hemorheol. Microcirc. 2023;83:247&#x2013;271. doi: 10.3233/CH-221634.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-221634</ArticleId><ArticleId IdType="pubmed">36502308</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A., Crincoli E., Savastano M.C., Younis S., Gambini G., De Vico U., Cozzupoli G.M., Culiersi C., Rizzo S. Gemelli Against Covid-Post-Acute Care Study Group. Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients. J. Clin. Med. 2020;9:2895. doi: 10.3390/jcm9092895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092895</ArticleId><ArticleId IdType="pmc">PMC7565672</ArticleId><ArticleId IdType="pubmed">32911619</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Zamora J., Bilbao-Malav&#xe9; V., G&#xe1;ndara E., Casablanca-Pi&#xf1;era A., Boquera-Ventosa C., Landecho M.F., Zarranz-Ventura J., Garc&#xed;a-Layana A. Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography. Biomedicines. 2021;9:247. doi: 10.3390/biomedicines9030247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030247</ArticleId><ArticleId IdType="pmc">PMC7998142</ArticleId><ArticleId IdType="pubmed">33801324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilbao-Malav&#xe9; V., Gonz&#xe1;lez-Zamora J., Saenz de Viteri M., de la Puente M., G&#xe1;ndara E., Casablanca-Pi&#xf1;era A., Boquera-Ventosa C., Zarranz-Ventura J., Landecho M.F., Garc&#xed;a-Layana A. Persistent Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia at 6-Months Follow-Up Assessed by Optical Coherence Tomography Angiography. Biomedicines. 2021;9:502. doi: 10.3390/biomedicines9050502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9050502</ArticleId><ArticleId IdType="pmc">PMC8147391</ArticleId><ArticleId IdType="pubmed">34063291</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrishami M., Emamverdian Z., Shoeibi N., Omidtabrizi A., Daneshvar R., Saeidi Rezvani T., Saeedian N., Eslami S., Mazloumi M., Sadda S., et al. Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: A case-control study. Can. J. Ophthalmol. 2021;56:24&#x2013;30. doi: 10.1016/j.jcjo.2020.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7666612</ArticleId><ArticleId IdType="pubmed">33249111</ArticleId></ArticleIdList></Reference><Reference><Citation>Guemes-Villahoz N., Burgos-Blasco B., Vidal-Villegas B., Donate-L&#xf3;pez J., de la Muela M.H., L&#xf3;pez-Guajardo L., Mart&#xed;n-S&#xe1;nchez F.J., Garc&#xed;a-Feijo&#xf3; J. Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography. Graefes Arch. Clin. Exp. Ophthalmol. 2021;259:2243&#x2013;2249. doi: 10.1007/s00417-021-05186-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-021-05186-0</ArticleId><ArticleId IdType="pmc">PMC8102150</ArticleId><ArticleId IdType="pubmed">33961108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazar L., Karahan M., Vural E., Ava S., Erdem S., Dursun M.E., Keklik&#xe7;i U. Macular vessel density in patients recovered from COVID 19. Photodiagnosis Photodyn. Ther. 2021;34:102267. doi: 10.1016/j.pdpdt.2021.102267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2021.102267</ArticleId><ArticleId IdType="pmc">PMC7999941</ArticleId><ArticleId IdType="pubmed">33785439</ArticleId></ArticleIdList></Reference><Reference><Citation>Cennamo G., Reibaldi M., Montorio D., D&#x2019;Andrea L., Fallico M., Triassi M. Optical Coherence Tomography Angiography Features in Post-COVID-19 Pneumonia Patients: A Pilot Study. Am. J. Ophthalmol. 2021;227:182&#x2013;190. doi: 10.1016/j.ajo.2021.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2021.03.015</ArticleId><ArticleId IdType="pmc">PMC7997850</ArticleId><ArticleId IdType="pubmed">33781767</ArticleId></ArticleIdList></Reference><Reference><Citation>Erogul O., Gobeka H.H., Dogan M., Akdogan M., Balci A., Kasikci M. Retinal microvascular morphology versus COVID-19: What to anticipate? Photodiagnosis Photodyn. Ther. 2022;39:102920. doi: 10.1016/j.pdpdt.2022.102920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2022.102920</ArticleId><ArticleId IdType="pmc">PMC9116963</ArticleId><ArticleId IdType="pubmed">35597442</ArticleId></ArticleIdList></Reference><Reference><Citation>Dipu T., Goel R., Arora R., Thakar M., Gautam A., Shah S., Gupta Y., Chhabra M., Kumar S., Singh K., et al. Ocular sequelae in severe COVID-19 recovered patients of second wave. Indian. J. Ophthalmol. 2022;70:1780&#x2013;1786. doi: 10.4103/ijo.IJO_2882_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_2882_21</ArticleId><ArticleId IdType="pmc">PMC9332963</ArticleId><ArticleId IdType="pubmed">35502072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kal M., Winiarczyk M., Cie&#x15b;la E., P&#x142;atkowska-Adamska B., Walczyk A., Biskup M., Pabjan P., G&#x142;uszek S., Odrobina D., Mackiewicz J., et al. Retinal Microvascular Changes in COVID-19 Bilateral Pneumonia Based on Optical Coherence Tomography Angiography. J. Clin. Med. 2022;11:3621. doi: 10.3390/jcm11133621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11133621</ArticleId><ArticleId IdType="pmc">PMC9267319</ArticleId><ArticleId IdType="pubmed">35806907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaw F.G.P., Warter A., Cavichini M., Knight D., Li A., Deussen D., Galang C., Heinke A., Mendoza V., Borooah S., et al. Retinal tissue and microvasculature loss in COVID-19 infection. Sci. Rep. 2023;13:5100. doi: 10.1038/s41598-023-31835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-31835-x</ArticleId><ArticleId IdType="pmc">PMC10050819</ArticleId><ArticleId IdType="pubmed">36991025</ArticleId></ArticleIdList></Reference><Reference><Citation>Urfalio&#x11f;lu S., Akk&#xf6;k B., &#xd6;zdemir G., Daghan B., Guler M. OCTA evaluation of posterior ocular blood flow in patients after COVID-19 infection without pneumonia. J. Fr. Ophtalmol. 2023;46:468&#x2013;474. doi: 10.1016/j.jfo.2023.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfo.2023.01.002</ArticleId><ArticleId IdType="pmc">PMC10036299</ArticleId><ArticleId IdType="pubmed">37019782</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Haddad N.S.E.M., Abd El-Wahed E., Abd El-Wahab A., Shalaby S., Farag M.M.A., Mohammed N.S., Shawky S. The Effect of Post-Coronavirus Disease 2019 Infection on the Retinal Microvasculature. J. Curr. Ophthalmol. 2023;35:50&#x2013;55. doi: 10.4103/joco.joco_273_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/joco.joco_273_22</ArticleId><ArticleId IdType="pmc">PMC10481977</ArticleId><ArticleId IdType="pubmed">37680283</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xdc;&#xe7;er M.B., Cevher S. How does Covid-19 affect the choroidal structures at the early post-infectious period? J. Fr. Ophtalmol. 2023;46:106&#x2013;113. doi: 10.1016/j.jfo.2022.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfo.2022.08.003</ArticleId><ArticleId IdType="pmc">PMC9771749</ArticleId><ArticleId IdType="pubmed">36585332</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I., Schulze A., Evers G., Harmening K., Vink H., K&#xfc;mpers P., Mohr M., Rovas A. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26:53&#x2013;61. doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;akmak F., Demirbuga A., Demirkol D., G&#xfc;m&#xfc;&#x15f; S., Torun S.H., Kayaalp G.K., &#xd6;meroglu R.E., Somer A., Uysalol M., Y&#x131;ld&#x131;z R., et al. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc. Res. 2021;138:104196. doi: 10.1016/j.mvr.2021.104196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2021.104196</ArticleId><ArticleId IdType="pmc">PMC8190529</ArticleId><ArticleId IdType="pubmed">34097919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulli A., Gotelli E., Bica P.F., Schiavetti I., Pizzorni C., Alo&#xe8; T., Grosso M., Barisione E., Paolino S., Smith V., et al. Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors. Microvasc. Res. 2022;142:104361. doi: 10.1016/j.mvr.2022.104361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2022.104361</ArticleId><ArticleId IdType="pmc">PMC8942583</ArticleId><ArticleId IdType="pubmed">35339493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazantzis D., Machairoudia G., Theodossiadis G., Theodossiadis P., Chatziralli I. Retinal microvascular changes in patients recovered from COVID-19 compared to healthy controls: A meta-analysis. Photodiagnosis Photodyn. Ther. 2023;42:103556. doi: 10.1016/j.pdpdt.2023.103556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2023.103556</ArticleId><ArticleId IdType="pmc">PMC10072975</ArticleId><ArticleId IdType="pubmed">37023998</ArticleId></ArticleIdList></Reference><Reference><Citation>Polak S.B., Van Gool I.C., Cohen D., von der Th&#xfc;sen J.H., van Paassen J. A systematic review of pathological findings in COVID-19: A pathophysiological timeline and possible mechanisms of disease progression. Mod. Pathol. 2020;33:2128&#x2013;2138. doi: 10.1038/s41379-020-0603-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-0603-3</ArticleId><ArticleId IdType="pmc">PMC7306927</ArticleId><ArticleId IdType="pubmed">32572155</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B. Prevalence of readily detected amyloid blood clots in &#x2018;unclotted&#x2019; Type 2 Diabetes Mellitus and COVID-19 plasma: A preliminary report. Cardiovasc. Diabetol. 2020;19:193. doi: 10.1186/s12933-020-01165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung E.M., Stroszczynski C., Jung F. Contrast enhanced ultrasonography (CEUS) to detect abdominal microcirculatory disorders in severe cases of COVID-19 infection: First experience. Clin. Hemorheol. Microcirc. 2020;74:353&#x2013;361. doi: 10.3233/CH-209003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-209003</ArticleId><ArticleId IdType="pmc">PMC7369109</ArticleId><ArticleId IdType="pubmed">32333581</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos A.C., Bonaca M.P. Studying the coagulopathy of COVID-19. Lancet. 2022;399:118&#x2013;119. doi: 10.1016/S0140-6736(21)01906-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01906-1</ArticleId><ArticleId IdType="pmc">PMC8598181</ArticleId><ArticleId IdType="pubmed">34800425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelliher S., Weiss L., Cullivan S., O&#x2019;rourke E., Murphy C.A., Toolan S., Lennon &#xc1;., Szklanna P.B., Comer S.P., Macleod H., et al. Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis. J. Thromb. Haemost. 2022;20:1008&#x2013;1014. doi: 10.1111/jth.15660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15660</ArticleId><ArticleId IdType="pmc">PMC9305123</ArticleId><ArticleId IdType="pubmed">35102689</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson O., Pillai S., Howard M., Zaldua J.C., Whitley J., Burgess B., Lawrence M., Hawkins K., Morris K., Evans P.A. Impaired fibrinolysis in severe COVID-19 infection is detectable in early stages of the disease. Clin. Hemorheol. Microcirc. 2022;82:183&#x2013;191. doi: 10.3233/CH-221491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-221491</ArticleId><ArticleId IdType="pubmed">35694917</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S.W., Ilyas I., Weng J.P. Endothelial dysfunction in COVID-19: An overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol. Sin. 2023;44:695&#x2013;709. doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Badaras I., Lau&#x10d;yt&#x117;-Cibulskien&#x117; A. Vascular Aging and COVID-19. Angiology. 2023;74:308&#x2013;316. doi: 10.1177/00033197221121007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197221121007</ArticleId><ArticleId IdType="pmc">PMC9421419</ArticleId><ArticleId IdType="pubmed">36031949</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R.W., Brown R.L., Benjamin L., Nortley R., Wiethoff S., Bharucha T., Jayaseelan D.L., Kumar G., Raftopoulos R.E., Zambreanu L., et al. The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain. 2020;143:3104&#x2013;3120. doi: 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheim D.E., Vottero P., Santin A.D., Hirsh A.G. Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19. Int. J. Mol. Sci. 2023;24:17039. doi: 10.3390/ijms242317039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms242317039</ArticleId><ArticleId IdType="pmc">PMC10871123</ArticleId><ArticleId IdType="pubmed">38069362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: Evidence, mechanisms, and therapeutic implications. Biochem. J. 2022;479:1653&#x2013;1708. doi: 10.1042/BCJ20220154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O&#x2019;Sullivan O., et al. Long COVID: Mechanisms, risk factors and recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: A proof of concept and mechanism study. Mol. Psychiatry. 2023;28:564&#x2013;578. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafet&#xe1; M.L., Souza V.C., Menezes T.C.F., Verrastro C.G.Y., Mancuso F.J., Albuquerque A.L.P., Tanni S.E., Izbicki M., Carlstron J.P., Nery L.E., et al. Exercise intolerance in post-coronavirus disease 2019 survivors after hospitalization. ERJ Open Res. 2023;9:00538&#x2013;02022. doi: 10.1183/23120541.00538-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00538-2022</ArticleId><ArticleId IdType="pmc">PMC10204824</ArticleId><ArticleId IdType="pubmed">37228270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareau M.G., Barrett K.E. Role of the microbiota-gut-brain axis in postacute COVID syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 2023;324:G322&#x2013;G328. doi: 10.1152/ajpgi.00293.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00293.2022</ArticleId><ArticleId IdType="pmc">PMC10042594</ArticleId><ArticleId IdType="pubmed">36880667</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss A.B., Greene C., Dayaramani C., Rauchman S.H., Stecker M.M., De Leon J., Pinkhasov A. Long COVID, the brain, nerves, and cognitive function. Neurol. Int. 2023;15:821&#x2013;841. doi: 10.3390/neurolint15030052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15030052</ArticleId><ArticleId IdType="pmc">PMC10366776</ArticleId><ArticleId IdType="pubmed">37489358</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu-Bercu A., Lobiuc A., C&#x103;liman-Sturdza O.A., Oi&#x163;&#x103; R.C., Iavorschi M., Pav&#x103;l N.E., &#x218;old&#x103;nescu I., Dimian M., Covasa M. Long COVID: Molecular Mechanisms and Detection Techniques. Int. J. Mol. Sci. 2023;25:408. doi: 10.3390/ijms25010408.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25010408</ArticleId><ArticleId IdType="pmc">PMC10778767</ArticleId><ArticleId IdType="pubmed">38203577</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziolos N.R., Ioannou P., Baliou S., Kofteridis D.P. Long COVID-19 Pathophysiology: What Do We Know So Far? Microorganisms. 2023;11:2458. doi: 10.3390/microorganisms11102458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11102458</ArticleId><ArticleId IdType="pmc">PMC10609046</ArticleId><ArticleId IdType="pubmed">37894116</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor M., McGrath O., Drira I., Aslam T. Retinal Microvasculature Image Analysis Using Optical Coherence Tomography Angiography in Patients with Post-COVID-19 Syndrome. J. Imaging. 2023;9:234. doi: 10.3390/jimaging9110234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jimaging9110234</ArticleId><ArticleId IdType="pmc">PMC10672226</ArticleId><ArticleId IdType="pubmed">37998081</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2. Erratum in: Nat. Rev. Microbiol. 2023, 21, 408. doi: 10.1038/s41579-023-00896-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>